Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: May 27, 2011 (rev. 1)

Premium

Exosome Diagnostics, a developer of biofluid-based molecular diagnostic tests for personalized medicine, has selected John Quackenbush to serve on its scientific advisory board.

Quackenbush is professor of computational biology and bioinformatics at the Dana-Faber Cancer Institute. Currently, his research focuses include the identification of expression fingerprints and genomic alterations that are relevant to colon and breast tumor metastasis; the development of novel computational approaches for the interpretation of large-scale datasets; and methods for data integration to facilitate gene discovery.

He completed a PhD in theoretical physics followed by a two-year postdoctoral position in experimental particle physics and phenomenology both at the University of California, Los Angeles.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more